News
1h
Audacy on MSNThere's a new, highly effective HIV drug on the marketA revolutionary new preventative medicine that protects against the HIV virus has just been approved by the U.S. Food and ...
The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across ...
Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be ...
This month, lenacapavir is expected to receive FDA approval for pre-exposure prophylaxis (PrEP). It could very well be that ...
Lenacapavir, a twice-yearly HIV prevention shot by Gilead, could be produced for $25 a year but may sell for $25K, raising ...
The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results